11 October 2021

Allen & Gledhill advised Asia Partners, as the lead investor, on the US$65.7 million Series C financing round of Doctor Anywhere. 

Doctor Anywhere is a regional tech-enabled, omnichannel healthcare company. Headquartered in Singapore and with a presence in six countries across the region, Doctor Anywhere currently serves more than 1.5 million users across South-east Asia.

This Series C financing round brings the total capital raised by Doctor Anywhere to more than S$140 million, and it is one of the largest private funding rounds ever raised by a healthtech company in South-east Asia.

Advising Asia Partners were Allen & Gledhill Counsel Julian Ho, and Partners Koh En Ying and Eugene Ho.

More

A&G News 21 March 2024

Allen & Gledhill named National Law Firm of the Year (Singapore) at the IFLR Asia-Pacific Awards 2024

Read more

A&G News 24 January 2024

A&G Asia officially opens Allen & Gledhill LLP Shanghai Representative Office (Singapore) on 24 January 2024

Read more